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ABSTRACT; 
Background; Acne Vulgaris leads to significant increase in psychological issues among patients and has negative 
impact on quality of life and their productivity. Objective; The objective of this study is to compare efficacy of 
0.1 % topical adapalenin gel versus 0.05 % isotretinoin gel in patients with mild to moderate acne vulgaris. 
Material and Methods; Group A, having 30 patients, was treated with 0.1 % adapalene gel in the morning and 
evening (twice a day) while Group B, also having 30 patients treated with 0.05 % isotretinoin gel  twice a day for 
6 weeks. The patients were followed weekly till 6 weeks from the beginning of therapy to observe efficacy. 
Results; Of these 60 study cases, 18 (30.0 %) were male patients while 42 (60.0 %) were female patients. Mean 
age of our study cases was 20.43 ± 3.37 years. Mean body mass index of our study cases was 25.12 ± 2.21 kg/m2 
and obesity was present in 13 (21.7 %) of our study cases. Of these 60 study cases, 30 (50%) had mild acne and 
30 (50%) moderate acne Mean disease duration was 4.52 ± 2.68 months and 54 (90.0 %) had duration of illness 
up to 6 months. Of these 60 study cases, 17 (28.3 %) were illiterate and 43 (71.7 %) were literate. Efficacy was 
noted in 35 (58.3%), in group A efficacy was noted to be 23 (76.7%) and efficacy in group B was noted be 12 
(40.0%). (P=0.008). Conclusion; Adapalene gel was found to be more effective, safe and reliable therapy for the 
treatment of mild to moderate acne as this therapy was significantly more efficacious as compared with 0.05 % 
isotretinoin gel. Our study results support the use of Adapalene gel for the treatment of mild to moderate acne as 
it provides desired outcomes which leads to improvement in quality of life these patients and also their 
productivity. This will also provide psychological relief to the patients having significant burden of psychological 
stress. 
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INTRODUCTION; 
Acne is a chronic inflammatory disease of pilosebaceous units. It is characterized by seborrhea, the 
formation of open and closed comedones, eryhtematous papules and pustules and in more severe cases nodules, 
deep pustules and pseudocyst. It is a common dermatologic disease that is usually managed by application of 
topical preparations, systemic medications, or a combination of the two 1-4 And is commonest skin disease, mainly 
in young ages, which dermatologists have to encounter in their daily routine 5. Antibiotics play a pivotal role in 
treatment. However, the emergence of new resistant strains or cross-resistance, development of various side 
effects, and poor tolerability are factors that sometimes limit their usefulness 6, 7.  
Acne vulgaris is a common condition extremely prevalent among teenagers and young adults under the age of 24 
years. Nearly 85% of adolescents in this age group experience some degree of acne. Acne lasts for several years 
and thus may significantly influence in many ways the lives of those affected. For many teens, the disease could 
create cosmetic, physical, and psychological scarring fueling anxiety, depression, and other emotional trauma that 
threaten their quality of life 8-11. Therefore, early and effective treatment is needed to save these patients from all 
the possible complications. Successful treatment of acne is significantly affected by the level of knowledge of the 
patients 12. 
Acne is usually diagnosed by the patient. The physician needs to determine if the condition is noninflammatory 
(open and closed comedones), inflammatory (papules or pustules) or a mixture of both (the most common 
situation). Many therapeutic options exist for treating acne including topical benzoyl peroxide, topical and oral 
antibiotics, topical and oral retinoids and oral contraceptives. Consensus guidelines advocate that the use of topical 
retinoids are primary treatment for most forms of acne treatment. However, all topical retinoids may be irritating 
which contribute to their underutilization. Topical adapalene has the advantage of causing less irritation and is 
more stable molecule than tretinoin 13. A study conducted by Khan et al14 reported efficacy with Adapalene was 
84.2 %  while it was 39.6 % with tretinoin group.  
This study was designed to document the efficacy of 0.1 % topical adapalene and 0.05 % tretinoin in the 
treatment of acne, as there is no such study done in our population previously but prevalence of acne is high in our 
population. Once the more effective treatment is documented in our population, the results will help to treat these 
patients more effectively which will relieve these patients from psychological and social problems which will 
improve quality of life as well as productivity of these young patients.  
 
MATERIAL AND METHODS; 
Total 60 patients with mild to moderate acne of either sex aged 18 – 40 years of age having duration more 
than 3 months were included in our study. Study was conducted in the OPD of Department of Medicine, Sheikh 
Zayed Medical College, Rahim Yar Khan. Patients taking anti-acne treatment within one month, having hirsutism, 
menstrual dysfunction, taking oral contraceptives, diabetes and hypertension were excluded from our study. 
Patients were randomly allocated in to two groups by lottery method.  Group A, having 30 patients, was treated 
with 0.1 % adapalene gel (about half of pea size amount for full face) in the morning and evening (twice a day) 
while Group B, also having 30 patients treated with 0.05 % isotretinoin gel  twice a day (about half of pea size 
amount for full face in morning and evening) for 6 weeks in patients with mild to moderate acne. The patients 
were followed weekly till 6 weeks from the beginning of therapy to observe efficacy. All the data was entered and 
analyzed using SPSS-20. Mean and standard deviation for the age, BMI of patient and duration of disease was 
calculated. Frequencies and percentage were calculated for the categorical variables like gender, disease severity 
(mild/moderate), age groups, efficacy (Present/Absent) and Obesity (Obese/Non-obese), family income, 
educational status. Efficacy was compared in both groups and chi-square test was applied for comparison of 
efficacy at level of significance of 0.05.  
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RESULTS; 
Our study comprised of a total of 60 patients meeting inclusion criteria of our study. Of these 60 study 
cases, 18 (30.0 %) were male patients while 42 (60.0 %) were female patients. Mean age of our study cases was 
20.43 ± 3.37 years (with minimum age of our study cases was 18 years while maximum age was 32 years). Mean 
age of the male patients was noted to be 19.28 ± 3.37 years while that female patients was 20.93 ± 3.29 years 
(p=0.083). Our study results have indicated that majority of our study cases i.e. 53 (88.3 %) were aged up to 30 
years. Of these 60 study cases, 25 (41.7 %) belonged to rural areas and 35 (58.3 %) belonged to urban areas. 
Monthly family income up Rs. 30000 was noted in 19 (31.7%) and more than 30000 rupees was noted in 41 
(68.3%). Mean body mass index of our study cases was 25.12 ± 2.21 kg/m2 and obesity was present in 13 (21.7 
%) of our study cases. Of these 60 study cases, 30 (50%) had mild acne and 30 (50%) moderate acne. Mean disease 
duration was 4.52 ± 2.68 months and 54 (90.0 %) had duration of illness up to 6 months. Of these 60 study cases, 
17 (28.3 %) were illiterate and 43 (71.7 %) were literate. Efficacy was noted in 35 (58.3%), in group A efficacy 
was noted to be 23 (76.7%) and efficacy in group B was noted be 12 (40.0%) (P=0.008).  
Table No. 9   Distribution of study cases by Efficacy. 
(n = 60) 
Efficacy 
(n=60) 
Group A Group B 
Frequency Percentage Frequency Percentage 
 
Yes 
n= 35 
(58.3 %) 
23 76.7 12 40.0 
 
No 
n=25 
(41.7 %) 
07 23.3 18 60.0 
Total 30 100 30 100 
* p = 0.008, which is statistically significant.  
 
DISCUSSION; 
Acne is one of the most common disorders treated by dermatologists and other health care providers. According 
to the Global Burden of Disease (GBD) study, acne vulgaris affects ~85% of young adults aged 12–25 years. The 
choice of therapy should be principally based on the type of lesion and the severity of the acne, but psychosocial 
disability relating to the disease and the presence of scarring may also influence the approach to treatment. 
Our study comprised of a total of 60 patients meeting inclusion criteria of our study. Of these 60 study 
cases, 18 (30.0 %) were male patients while 42 (60.0 %) were female patients. A study conducted by Batool et al 
15 from Rahim Yar Khan also documented 87 % female gender predominance which is in compliance with our 
study results. A study conducted by Ghafoor et al 16 from Karak has also documented 0.82:1.11 female gender 
predominance which is in compliance with our study results. Shaukat et al 17 from Lahore has also reported 80 % 
female gender predominance in acne patients which is close to our study results. A study conducted by Sohail et 
al 18 from Karachi has also reported 65 % female gender predominance which is close to our study results. An 
Indian study conducted by Hazarika et al 20 has also documented 56 % female gender predominance which is close 
to our study results. However another study from India conducted by Gupta et al 21 has reported 63 % male gender 
predominance which is different from our study results.  
Mean age of our study cases was 20.43 ± 3.37 years (with minimum age of our study cases was 18 years 
while maximum age was 32 years). Mean age of the male patients was noted to be 19.28 ± 3.37 years while that 
female patients was 20.93 ± 3.29 years (p=0.083). Our study results have indicated that majority of our study cases 
i.e. 53 (88.3 %) were aged up to 30 years. A study conducted by Batool et al 15 from Rahim Yar Khan also 
documented 18.8 ± 2.7 years mean age of the acne patients which is close to our study results. A study conducted 
by Ghafoor et al 16 from Karak has also documented 18.45 ± 2.91 years mean age which is close to our study 
results. Shaukat et al 17 from Lahore has also reported 20.45 ± 3.27 years mean age which is close to our study 
results.  A study conducted by Sohail et al 18 from Karachi has also reported 21.4 years mean age which is close to 
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our study results. another study from India conducted by Gupta et al 21 has reported 22.49 ± 5.38 years mean age 
which is close to our study results.  
Of these 60 study cases, 25 (41.7 %) belonged to rural areas and 35 (58.3 %) belonged to urban areas. 
Monthly family income up Rs. 30000 was noted in 19 (31.7%) and more than 30000 rupees was noted in 41 
(68.3%). A study conducted by Batool et al 15 from Rahim Yar Khan also documented 30.4 % patients of acne 
from rural areas which is in compliance with our study results.  
Mean body mass index of our study cases was 25.12 ± 2.21 kg/m2 and obesity was present in 13 (21.7 %) 
of our study cases. Of these 60 study cases, 30 (50%) had mild acne and 30 (50%) moderate acne. Mean disease 
duration was 4.52 ± 2.68 months and 54 (90.0 %) had duration of illness up to 6 months.  Of these 60 study cases, 
17 (28.3 %) were illiterate and 43 (71.7 %) were literate. A study conducted by Batool et al 15 from Rahim Yar 
Khan also reported similar results.  
Efficacy was noted in 35 (58.3%), in group A efficacy was noted to be 23 (76.7%) and efficacy in group 
B was noted be 12 (40.0%) (P=0.008). A study conducted by Khan et al14 reported efficacy with Adapalene was 
84.2 %  while it was 39.6 % with tretinoin group. These findings are close to our study results. Another study 
conducted by Loannides et al 22 in Greece also reported Adapalene being more effective than tretinoin group which 
is similar to that of our study results.  
 
CONCLUSION; 
Adapalene gel was found to be more effective, safe and reliable therapy for the treatment of mild to moderate acne 
as this therapy was significantly more efficacious as compared with 0.05 % isotretinoin gel. Our study results 
support the use of Adapalene gel for the treatment of mild to moderate acne as it provides desired outcomes which 
leads to improvement in quality of life these patients and also their productivity. This will also provide 
psychological relief to our patients as it is associated with significant burden of psychological stress.  
 
REFERENCES 
1. Hsu P, Litman GI, Brodell RT. Overview of the treatment of acne vulgaris with topical 
retinoids. Postgrad Med. 2011;123:153–61. 
2. Kraft J, Freiman A. Management of acne. CMAJ. 2011;183:430–5. 
3. Smith EV, Grindlay DJ, Williams HC. What's new in acne.? An analysis of systematic reviews 
published in 2009-2010. Clin Exp Dermatol. 2011;36:119–22.  
4. Faghihi G, Rakhshanpour M, Abtahi-Naeini B, Nilforoushzadeh MA. The efficacy of 5% dapsone gel 
plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: a randomized double-blind study. 
Adv Biomed Res. 2014;3:177. doi:  10.4103/2277-9175.139413. 
5. Simonart T. Newer approaches to the treatment of acne vulgaris. Am J Clin Dermatol. 2012;13(6):357-
64.  
6. Ingram JR, Grindlay DJ, Williams HC. Management of acne vulgaris: an evidence-based update. Clin 
Exp Dermatol. 2010;35:351–4. 
7. Canavan TN1, Chen E1, Elewski BE2. Optimizing non-antibiotic treatments for patients with acne: a 
review. Dermatol Ther (Heidelb). 2016 Dec;6(4):555-578. 
8. Cao H1, Yang G, Wang Y, Liu JP, Smith CA, Luo H, et al.  Complementary therapies for acne vulgaris. 
Cochrane Database Syst Rev. 2015 Jan 19;1:CD009436. doi: 10.1002/14651858.CD009436.pub2. 
9. Bez Y, Yesilova Y, Ari M, Kaya MC, Alpak G, Bulut M. Predictive value of obsessive compulsive 
symptoms involving the skin on quality of life in patients with acne vulgaris. Acta Derm Venereol. 
2013;93:679–83. 
10. Timms RM. Moderate acne as a potential barrier to social relationships: Myth or reality? Psychol 
Health Med. 2013;18:310–20.  
11. Gupta MA, Gupta AK. Evaluation of cutaneous body image dissatisfaction in the dermatology patient. 
Clin Dermatol. 2013;31:72–9.  
12. Magin P. Appearance-related bullying and skin disorders. Clin Dermatol. 2013;31:66–71 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal  
Vol.61, 2019 
 
43 
13. Al-Natour SH1. Acne vulgaris: Perceptions and beliefs of Saudi adolescent males. J Family Community 
Med. 2017;24(1):34-43.  
14. Khan M, Khan NU, Anwar MI, Noor SM. A comparison of efficacy of topical adapalene gel 0.1% with 
tretinoin gel 0.025 % in mild acne vulgaris. J Pak Assoc Dermatol. 2017;27(1):37-41 
15. Batool S, Mustafa G, Hanif M, Mahmood N, Sadia F, Hassan M. Perception of acne patients regarding 
its pathogenesis and treatment. J Sheikh Zayed Med Coll. 2010;1(2):60-4. 
16. Ullah G, Noor SM, Bhatti Z, Ahmad M, Bangash AR. Comparison of oral azithromycin with oral 
doxycycline in the treatment of acne vulgaris. J Ayub Med Coll Abottabad. 2014;26(1):64-7. 
17. Shaukat S, Aman S, Hussain I, Kazmi AH. The effect of oral doxycycline and topical 5% benzoyl 
peroxide on quality of life in patients with mild to moderate acne vulgaris. J Pak Assoc Derma. 
2013;23(2):173-9.  
18. Ahmed S, Ahmed I. Frequency and magnitude of anxiety and depression among acne patients: a study 
of 100 cases J Liaquat Uni Med Health Sci. 2007;6(1):25-9. 
19. Naeem, Akram B, Luqman L. Acne vulgaris; psychosocial stressors in patients 
Professional Med J. 2013;20(3):403-8. 
20. Hazarika N, Archana M. The Psychosocial impact of acne vulgaris. Indian J Dermatol. 2016;61(5):515–
20. 
21. Gupta A, Sharma YK, Dash KN, Chaudhari ND, Jethani S. Quality of life in acne vulgaris: Relationship 
to clinical severity and demographic data. Indian J Dermatol Venereol Leprol. 2016;82:292-7.  
22. Ioannides D1, Rigopoulos D, Katsambas A. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the 
treatment of acne vulgaris: a randomized open-label clinical trial. Br J Dermatol. 2002 Sep;147(3):523-
7. 
 
 
